Skip to main content

Articles

Page 54 of 76

  1. Medulloblastoma (MB) is the most common pediatric brain tumor. Current treatment regimes consisting of primary surgery followed by radio- and chemotherapy, achieve 5-year overall survival rates of only about 6...

    Authors: Ina Patties, Rolf-Dieter Kortmann, Franziska Menzel and Annegret Glasow
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:94
    Content type: Research Published on:

  2. MicroRNAs (miRNAs) are small non-coding RNAs frequently dysregulated in human malignant tumors. In the present study, we analyzed the role miR-155-3p plays in Hepatocellular carcinoma (HCC), which has been rep...

    Authors: Bo Tang, Biao Lei, Guangying Qi, Xingsi Liang, Fang Tang, Shengguang Yuan, Zhenran Wang, Shuiping Yu and Songqing He
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:93
    Content type: Research Published on:

  4. MUC4 is a high molecular weight membrane protein that is overexpressed in pancreatic cancer (PC) and is associated with the development and progression of this disease. However, the exact mechanisms through wh...

    Authors: Jie Tang, Yi Zhu, Kunling Xie, Xiaoyu Zhang, Xiaofei Zhi, Weizhi Wang, Zheng Li, Qun Zhang, Linjun Wang, Jiwei Wang and Zekuan Xu
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:91
    Content type: Research Published on:

    The Erratum to this article has been published in Journal of Experimental & Clinical Cancer Research 2017 36:34

  5. Glioma is one of the most common and aggressive primary malignant tumor in the brain. Accumulating evidences indicated that aberrantly expressed non-coding RNAs (ncRNAs), including long non-coding RNAs (lncRNA...

    Authors: Chun-Chun Ma, Zhang Xiong, Guan-Nan Zhu, Chao Wang, Gang Zong, Hong-Liang Wang, Er-Bao Bian and Bing Zhao
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:90
    Content type: Research Published on:

  6. Increasing evidence suggests that microRNAs (miRNAs) play critical roles in malignant transformation, tumor progression and metastasis. Aberrant miR-655-3p expression has been associated with several cancers. ...

    Authors: Gang Wu, Kunming Zheng, Shuguan Xia, Yawei Wang, Xiangyu Meng, Xiaoming Qin and Ying Cheng
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:89
    Content type: Research Published on:

  7. Epithelial-mesenchymal transition (EMT) is a crucial step for solid tumor progression and plays an important role in cancer invasion and metastasis. RNF8 is an ubiquitin E3 ligase with RING domain, and plays e...

    Authors: Jingyu Kuang, Li Li, Limei Guo, Yanrong Su, Yuxuan Wang, Yongjie Xu, Xiaozhen Wang, Shucong Meng, Liandi Lei, Luzheng Xu and Genze Shao
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:88
    Content type: Research Published on:

  8. The role of HBV X protein (HBx) in the development of hepatocellular carcinoma (HCC) has been well studied. However, little is known about the molecular functions of HBV whole-X protein (HBwx), a protein fused...

    Authors: Yu Zhang, Hongli Liu, Ruitian Yi, Taotao Yan, Yingli He, Yingren Zhao and Jinfeng Liu
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:87
    Content type: Research Published on:

  9. Mutations in isocitrate dehydrogenase 1 (IDH1) and isocitrate dehydrogenase 2 (IDH2) are frequent in low-grade gliomas and secondary glioblastomas (sGBM). Because they yield the same oncometabolite, D-2-hydroxygl...

    Authors: Hao-Yuan Wang, Kai Tang, Ting-Yu Liang, Wei-Zhong Zhang, Ji-Ye Li, Wen Wang, Hui-Min Hu, Ming-Yang Li, Hui-Qing Wang, Xiao-Zheng He, Zhi-Yuan Zhu, Yan-Wei Liu and Shi-Zhong Zhang
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:86
    Content type: Research Published on:

  10. Hepatectomy generally offers the best chance of long-term survival for patients with hepatocellular carcinoma (HCC). Many studies have shown that hepatectomy accelerates tumor metastasis, but the mechanism rem...

    Authors: Xiu-Yan Huang, Zi-Li Huang, Bin Xu, Zi Chen, Thomas Joseph Re, Qi Zheng, Zhao-You Tang and Xin-Yu Huang
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:85
    Content type: Research Published on:

    The Erratum to this article has been published in Journal of Experimental & Clinical Cancer Research 2016 35:102

  11. The transcription factor Yin Yang 1 (YY1) is frequently overexpressed in cancerous tissues compared to normal tissues and has regulatory roles in cell proliferation, cell viability, epithelial-mesenchymal tran...

    Authors: Samantha Kaufhold, Hermes Garbán and Benjamin Bonavida
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:84
    Content type: Review Published on:

  12. Long non-coding RNAs (lncRNAs) have emerged as biomarkers and important regulators of tumor development and progression. PANDAR (promoter of CDKN1A antisense DNA damage activated RNA) is a novel long non-codin...

    Authors: Yonghao Zhan, Junhao Lin, Yuchen Liu, Mingwei Chen, Xiaoying Chen, Chengle Zhuang, Li Liu, Wen Xu, Zhicong Chen, Anbang He, Qiaoxia Zhang, Xiaojuan Sun, Guoping Zhao and Weiren Huang
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:83
    Content type: Research Published on:

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2023 42:185

  13. Increasing evidence supports the association of CTNND1 with tumor development and progression. However, the mechanism and clinical significance of CTNND1 deregulation in hepatocellular carcinoma (HCC) remains ...

    Authors: Bo Tang, Fang Tang, Zhenran Wang, Guangying Qi, Xingsi Liang, Bo Li, Shengguang Yuan, Jie Liu, Shuiping Yu and Songqing He
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:82
    Content type: Research Published on:

  15. It was reported that metastases might occur via transfer of biologically active blood circulating molecules from the primary tumor to distant organs rather than only migration of cancer cells. We showed in an ...

    Authors: Dana Hamam, Mohamed Abdouh, Zu-Hua Gao, Vincenzo Arena, Manuel Arena and Goffredo Orazio Arena
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:80
    Content type: Research Published on:

  16. Tumor cells use aerobic glycolysis to rapidly generate ATP and growth substrate which expenses a large amount of glucose. However, how tumor cells take in enough glucose from the tumor microenvironment of insu...

    Authors: Shixiong Lei, Jiandong Yang, Chong Chen, Jiachen Sun, Liu Yang, Haili Tang, Tao Yang, An Chen, Huadong Zhao, Yan Li and Xilin Du
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:79
    Content type: Research Published on:

  17. Glioblastoma multiforme is the most aggressive malignant primary brain tumor, characterized by rapid growth and extensive infiltration to neighboring normal brain parenchyma. Both PI3K/Akt and JNK pathways are...

    Authors: Hua-Fu Zhao, Jing Wang, Hao-Ran Jiang, Zhong-Ping Chen and Shing-Shun Tony To
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:78
    Content type: Research Published on:

  19. Lung cancer is the most common malignancies worldwide. However, the detailed molecular mechanisms underlying lung cancer progression are still not completely clear. MicroRNAs are small noncoding RNAs which occ...

    Authors: Wei Chen, Jun Wang, Sulai Liu, Shaoqiang Wang, Yuanda Cheng, Wolong Zhou, Chaojun Duan and Chunfang Zhang
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:76
    Content type: Research Published on:

  20. Recent evidence has proven that long noncoding RNAs (lncRNAs) play important roles in cancer biology, while few lncRNAs have been characterized in NSCLC. Here, we characterized a novel lncRNA, SBF2 antisense R...

    Authors: Junjie Lv, Mantang Qiu, Wenjia Xia, Chao Liu, Youtao Xu, Jie Wang, Xuechun Leng, Su Huang, Rong Zhu, Ming Zhao, Fengqing Ji, Lin Xu, Keping Xu and Rong Yin
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:75
    Content type: Research Published on:

  21. Gene-based virotherapy mediated by oncolytic viruses is currently experiencing a renaissance in cancer therapy. However, relatively little attention has been given to the potentiality of dual gene virotherapy ...

    Authors: Adel Galal El-Shemi, Ahmad Mohammed Ashshi, Youjin Na, Yan Li, Mohammed Basalamah, Faisal Ahmad Al-Allaf, Eonju Oh, Bo-Kyeong Jung and Chae-Ok YUN
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:74
    Content type: Research Published on:

    The Erratum to this article has been published in Journal of Experimental & Clinical Cancer Research 2016 35:96

  22. Chemotherapy with docetaxel (Doc) remains the standard treatment for metastatic and castration-resistance prostate cancer (CRPC). However, the clinical success of Doc is limited by its chemoresistance and side...

    Authors: Piwen Wang, Susanne M. Henning, Clara E. Magyar, Yahya Elshimali, David Heber and Jaydutt V. Vadgama
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:73
    Content type: Research Published on:

  23. Abnormal DNA methylation/demethylation is recognized as a hallmark of cancer. TET (ten-eleven translocation) family members are novel DNA demethylation related proteins that dysregulate in multiple malignances...

    Authors: Zhongxue Ye, Jie Li, Xi Han, Huilian Hou, He Chen, Xia Zheng, Jiaojiao Lu, Lijie Wang, Wei Chen, Xu Li and Le Zhao
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:72
    Content type: Research Published on:

  24. Hepatocellular carcinoma (HCC) accounts for 75 % of liver cancers and is the second most lethal cancer, associated with its multiple etiologies, poor prognosis and resistance to chemotherapy drugs. Chemotherap...

    Authors: Zheng Hu, Guixiang Lv, Yongning Li, Enze Li, Haixia Li, Qi Zhou, Bin Yang and Wenwu Cao
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:71
    Content type: Research Published on:

  25. Aberrant expression of the RON receptor tyrosine kinase, a member of the MET proto-oncogene family, in breast cancer and non-small cell lung cancer (NSCLC) has therapeutic implication. Here we evaluated the ef...

    Authors: Liang Feng, Hang-Ping Yao, Sharad Sharma, Yong-Qing Zhou, Jianwei Zhou, Ruiwen Zhang and Ming-Hai Wang
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:70
    Content type: Research Published on:

    The Erratum to this article has been published in Journal of Experimental & Clinical Cancer Research 2016 35:95

  26. MicroRNA-138 (miR-138) has been proven to be a tumor suppressor gene in various types of tumors. However, the expression and the role of miR-138 in human osteosarcoma are still poorly understood. We investigat...

    Authors: Baoen Jiang, Weidong Mu, Jiangquan Wang, Jianshu Lu, Shanyong Jiang, Liang Li, Haining Xu and Hongyan Tian
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:69
    Content type: Research Published on:

  27. Prohibitin (PHB), a pleiotropic protein overexpressed in several tumor types, has been implicated in the regulation of cell proliferation, invasive migration and survival. However, PHB expression and its biolo...

    Authors: Yang Cao, Haibin Liang, Fei Zhang, Zhou Luan, Shuai Zhao, Xu-an Wang, Shibo Liu, Runfa Bao, Yijun Shu, Qiang Ma, Jian Zhu and Yingbin Liu
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:68
    Content type: Research Published on:

  28. Hepatocellular carcinoma (HCC) remains a major public health problem worldwide. The identification of effective chemotherapeutic targets for advanced HCC patients is urgently required. In this study, we invest...

    Authors: Qunying Zhuang, Tengjian Zhou, Chengyong He, Shili Zhang, Yang Qiu, Bing Luo, Ran Zhao, Hengchuan Liu, Yuchun Lin and Zhongning Lin
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:67
    Content type: Research Published on:

  29. Circulating tumor cells (CTCs) hold great potential in both clinical application and basic research for the managements of cancer. However, it remains to be an enormous challenge to obtain efficient detection ...

    Authors: Yang Gao, Yayun Zhu, Zhenzhen Zhang, Cheng Zhang, Xinyu Huang and Zhou Yuan
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:66
    Content type: Research Published on:

  30. Endothelial progenitor cells (EPCs) can migrate to the tumor tissue and enhance the angiogenesis of hepatocellular carcinoma (HCC); thus, they are associated with a poor prognosis. However, the specific molecu...

    Authors: Yi Wang, Haitao Yu, Yunfeng Shan, Chonglin Tao, Fang Wu, Zhengping Yu, Pengyi Guo, Jianfei Huang, Junjian Li, Qiandong Zhu, Fuxiang Yu, Qitong Song, Hongqi Shi, Mengtao Zhou and Gang Chen
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:65
    Content type: Research Published on:

  31. B-Acute lymphoblastic leukemia (B-ALL) represents a hematologic malignancy with poor clinical outcome and low survival rates in adult patients. Remission rates in Hispanic population are almost 30 % lower and ...

    Authors: Nataly Cruz-Rodriguez, Alba L. Combita, Leonardo J. Enciso, Sandra M. Quijano, Paula L. Pinzon, Olga C. Lozano, Juan S. Castillo, Li Li, Jose Bareño, Claudia Cardozo, Julio Solano, Maria V. Herrera, Jennifer Cudris and Jovanny Zabaleta
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:64
    Content type: Research Published on:

  32. Sonic hedgehog (SHH) plays critical roles in cell growth and development. Tumor cells express SHH, which can promote cell proliferation and epithelial-to-mesenchymal transition. However, the autocrine SHH path...

    Authors: Zhai Ertao, Chen Jianhui, Chen Chuangqi, Qin Changjiang, Chen Sile, He Yulong, Wu Hui and Cai Shirong
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:63
    Content type: Research Published on:

  33. The Hippo signaling acts as a tumor-suppressor pathway that negatively regulates TAZ and YAP. Increasing evidence supports the activation of TAZ and YAP in breast cancer. Moreover, the Hippo pathway is involve...

    Authors: Patrizia Vici, Cristiana Ercolani, Anna Di Benedetto, Laura Pizzuti, Luigi Di Lauro, Francesca Sperati, Irene Terrenato, Teresa Gamucci, Clara Natoli, Franco Di Filippo, Claudio Botti, Maddalena Barba, Marcella Mottolese, Ruggero De Maria and Marcello Maugeri-Saccà
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:62
    Content type: Research Published on:

  34. Evidences indicate that inflammatory process plays pivotal role in tumor disease. Soluble epoxide hydrolase inhibitors (sEHIs) have been shown to participate in anti-inflammation and tumorigenesis by protectin...

    Authors: Junyang Li, Chao Tang, Liwen Li, Rujun Li and Youwu Fan
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:61
    Content type: Research Published on:

  35. We conducted multiple microarray datasets analyses from clinical and xenograft tumor tissues to search for disease progression-driving oncogenes in prostate cancer (PCa). Sperm-associated antigen 5 (SPAG5) att...

    Authors: Hongtuan Zhang, Shadan Li, Xiong Yang, Baomin Qiao, Zhihong Zhang and Yong Xu
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:60
    Content type: Research Published on:

  36. Ursolic acid (UA), a natural pentacyclic triterpenoid, exerts anti-tumor effects in various cancer types including hepatocellular carcinoma (HCC). However, the molecular mechanisms underlying this remain large...

    Authors: LiJun Yang, Qing Tang, Jingjing Wu, Yuqing Chen, Fang Zheng, Zhenhui Dai and Swei Sunny Hann
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:59
    Content type: Research Published on:

    The Erratum to this article has been published in Journal of Experimental & Clinical Cancer Research 2016 35:81

  37. Microtubule Targeting Agents (MTAs) including paclitaxel, colchicine and vinca alkaloids are widely used in the treatment of various cancers. As with most chemotherapeutic agents, adverse effects and drug resi...

    Authors: Mohadeseh Hasanpourghadi, Chandrabose Karthikeyan, Ashok Kumar Pandurangan, Chung Yeng Looi, Piyush Trivedi, Kinue Kobayashi, Kozo Tanaka, Won Fen Wong and Mohd Rais Mustafa
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:58
    Content type: Research Published on:

  38. Gastric cancer remains a major cause of mortality and morbidity worldwide. In recent years, gene-based therapeutic strategies were confirmed promising in cancer inhibition and attracted great attention. RNA in...

    Authors: Hao Peng, Huawei Yang, Liwei Song, Zheng Zhou, Jinwen Sun, Yunfeng Du, Keyu Lu, Tao Li, Aiguo Yin, Jianhua Xu and Shidong Wei
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:57
    Content type: Research Published on:

  39. DNA topoisomerase I (Top1) is a DNA unwinding protein and the specific target of the camptothecin class of chemotherapeutic drugs. One of these, irinotecan, acting through its active metabolite SN-38, is used ...

    Authors: Niels Frank Jensen, Keli Agama, Amit Roy, David Hersi Smith, Thomas D. Pfister, Maria Unni Rømer, Hong-Liang Zhang, James H. Doroshow, Birgitta R. Knudsen, Jan Stenvang, Nils Brünner and Yves Pommier
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:56
    Content type: Research Published on:

  40. The CXCL12/CXCR4 pathway regulates tumor cell proliferation, metastasis, angiogenesis and the tumor-microenvironment cross-talk in several solid tumors, including glioblastoma (GBM), the most common and fatal ...

    Authors: Laura Mercurio, Maria Antonietta Ajmone-Cat, Serena Cecchetti, Alessandro Ricci, Giuseppina Bozzuto, Agnese Molinari, Isabella Manni, Bianca Pollo, Stefania Scala, Giulia Carpinelli and Luisa Minghetti
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:55
    Content type: Research Published on:

  41. Colon cancer is invariably accompanied by altered coagulation activity; however, the precise role of phosphatidylserine (PS) in the hypercoagulable state of colon cancer patients remains unclear. We explored t...

    Authors: Liangliang Zhao, Yayan Bi, Junjie Kou, Jialan Shi and Daxun Piao
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:54
    Content type: Research Published on:

  42. Previous study showed that dsP53-285 has the capacity to induce tumor suppressor gene p53 expression by targeting promoter in non-human primates’ cells. And it is well known that TP53 gene is frequently mutant...

    Authors: Chenghe Wang, Qiangqiang Ge, Qingsong Zhang, Zhong Chen, Jia Hu, Fan Li and Zhangqun Ye
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:53
    Content type: Research Published on:

  43. Activated B cell-like subtype of diffuse large B cell lymphoma (ABC-DLBCL) presents aggressive clinical courses and poor prognosis. Targeting key pathways may raise the possibility of improving clinical outcomes.

    Authors: Zhen Jin, Kai Qing, Yuan Ouyang, Zhao Liu, Wenfang Wang, Xiaoyang Li, Zizhen Xu and Junmin Li
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:52
    Content type: Research Published on:

  44. CC-chemokine receptor 7 (CCR7), which plays an important role in cell directional movement, is highly expressed in various cancers and positively related to lymph node metastasis. The inflammatory cytokine tum...

    Authors: HaiJie Hong, CaiLong He, SiYuan Zhu, YanHui Zhang, XiaoQian Wang, FeiFei She and YanLing Chen
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:51
    Content type: Research Published on:

  45. The aim of this analysis was to investigate the potential impact of Ki67 assay in a series of patients affected by early stage invasive lobular carcinoma (ILC) undergone surgery.

    Authors: Luisa Carbognin, Isabella Sperduti, Matteo Brunelli, Lisa Marcolini, Rolando Nortilli, Sara Pilotto, Ilaria Zampiva, Sara Merler, Elena Fiorio, Elisa Filippi, Erminia Manfrin, Francesca Pellini, Franco Bonetti, Giovanni Paolo Pollini, Giampaolo Tortora and Emilio Bria
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:50
    Content type: Research Published on:

  46. The achievement of complete response (CR) significantly correlates with a better clinical outcome in multiple myeloma (MM) patients treated with autologous stem cell transplant (ASCT). The depth of response is...

    Authors: Iole Cordone, Francesco Marchesi, Serena Masi, Valentina Summa, Francesco Pisani, Roberta Merola, Giovanni Cigliana, Giulia Orlandi, Svitlana Gumenyuk, Francesca Palombi, Atelda Romano, Antonio Spadea, Daniela Renzi, Elena Papa, Marco Canfora, Laura Conti…
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:49
    Content type: Research Published on:

  47. Adenylate kinase is a key enzyme in the high-energy phosphoryl transfer reaction in living cells. An isoform of this enzyme, adenylate kinase 4 (AK4), is localized in the mitochondrial matrix and is believed t...

    Authors: Koichi Fujisawa, Shuji Terai, Taro Takami, Naoki Yamamoto, Takahiro Yamasaki, Toshihiko Matsumoto, Kazuhito Yamaguchi, Yuji Owada, Hiroshi Nishina, Takafumi Noma and Isao Sakaida
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:48
    Content type: Research Published on:

  48. MicroRNAs (miRNAs) have been proved involved in many tumorigenic behaviors including tumor growth. But, the clinical significance and functions of miRNA-203 in gastric cancer (GC) remain elusive.

    Authors: Shao-Jun Chu, Ge Wang, Peng-Fei Zhang, Rui Zhang, Yan-Xia Huang, Yun-Min Lu, Wei Da, Qun Sun, Jing Zhang and Jin-Shui Zhu
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:47
    Content type: Research Published on:

    The Retraction Note to this article has been published in Journal of Experimental & Clinical Cancer Research 2017 36:61

  49. Progressive loss of skeletal muscle, termed muscle wasting, is a hallmark of cancer cachexia and contributes to weakness, reduced quality of life, as well as poor response to therapy. Previous studies have ind...

    Authors: Xiu-yan Huang, Zi-li Huang, Ju-hong Yang, Yong-hua Xu, Jiu-Song Sun, Qi Zheng, Chunyao Wei, Wei Song and Zhou Yuan
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:46
    Content type: Research Published on:

    The Erratum to this article has been published in Journal of Experimental & Clinical Cancer Research 2016 35:77

  50. A widespread decrease of mature microRNAs is often observed in human malignancies giving them potential to act as tumor suppressors. Thus, microRNAs may be potential targets for cancer therapy. The global miRN...

    Authors: Aymone Gurtner, Emmanuela Falcone, Francesca Garibaldi and Giulia Piaggio
    Citation: Journal of Experimental & Clinical Cancer Research 2016 35:45
    Content type: Review Published on:

Annual Journal Metrics

  • 2022 Citation Impact
    11.3 - 2-year Impact Factor
    11.5 - 5-year Impact Factor
    1.870 - SNIP (Source Normalized Impact per Paper)
    2.413 - SJR (SCImago Journal Rank)

    2023 Speed
    4 days submission to first editorial decision for all manuscripts (Median)
    100 days submission to accept (Median)

    2023 Usage 
    3,003,080 downloads
    3,022 Altmetric mentions

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us